Hospital Virgen de La Luz de Cuenca-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2024

  1. The prognostic value of blood cellular indices in pulmonary embolism

    American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711

2020

  1. Clinical characteristics and outcomes of venous thromboembolic events after hallux valgus surgery: insights from the RIETE registry

    Journal of Thrombosis and Thrombolysis, Vol. 49, Núm. 4, pp. 651-658

  2. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

    Thrombosis Update, Vol. 1

2019

  1. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

  2. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

    Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1

2018

  1. Thirty-day outcomes in patients with acute pulmonary embolism who discontinued anticoagulant therapy before 90 days

    American Heart Journal, Vol. 206, pp. 1-10

  2. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

    American Journal of Medicine, Vol. 131, Núm. 4, pp. 430-437

2017

  1. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

    Research and Practice in Thrombosis and Haemostasis, Vol. 1, Núm. 2, pp. 172-179

2015

  1. Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism

    Medicine (United States), Vol. 94, Núm. 32